Position in HIMS
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$86,188,003
-$61,520,752 QoQ
Shares Held
4,151,638
-8.7% QoQ
Ownership
1.79%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
19 quarters on record
Voting authority
Sole 99.19672668956204.ToString("F0")%
Shared 0.ToString("F0")%
None 0.8032733104379525.ToString("F0")%
Common Shares in HIMS Over Time
Shares Held
Position Value (USD)
Derivatives in HIMS
reported options exposure · as of Mar 31, 2026CallValue
$3,990,155
CallShares
192,204
PutValue
$3,529,200
PutShares
170,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026UBS Group AG holds $1,524,475,453 across 81 Drug Manufacturers - Specialty & Generic names. HIMS ranks #5 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
2,799,543 | $330,933,975 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
8,572,057 | $205,129,322 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
1,221,036 | $160,859,281 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
236,729 | $140,375,559 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
This page
|
4,151,638 | $86,188,003 | |
| 6 | INDV |
Indivior Pharmaceuticals, Inc.
|
2,192,264 | $66,820,205 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
867,675 | $65,813,148 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,877,217 | $56,541,775 |
All Filings in HIMS
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $86,188,003 | 4,151,638 | Shares | Defined | 2026-05-05 | |
| 2026-03-31 | $3,529,200 | 170,000 | Put | Defined | 2026-05-05 | |
| 2026-03-31 | $3,990,155 | 192,204 | Call | Defined | 2026-05-05 | |
| 2025-12-31 | $147,708,755 | 4,549,084 | Shares | Defined | 2026-01-29 | |
| 2025-12-31 | $4,815,430 | 148,304 | Call | Defined | 2026-01-29 | |
| 2025-09-30 | $162,447,779 | 2,864,030 | Shares | Defined | 2025-11-13 | |
| 2025-09-30 | $7,146,720 | 126,000 | Put | Defined | 2025-11-13 | |
| 2025-09-30 | $6,313,616 | 111,312 | Call | Defined | 2025-11-13 | |
| 2025-06-30 | $7,921,264 | 158,902 | Call | Defined | 2025-08-14 | |
| 2025-06-30 | $127,159,423 | 2,550,841 | Shares | Defined | 2025-08-14 | |
| 2025-06-30 | $9,411,680 | 188,800 | Put | Defined | 2025-08-14 | |
| 2025-03-31 | $52,822,987 | 1,787,580 | Shares | Defined | 2025-05-13 | |
| 2025-03-31 | $2,358,090 | 79,800 | Call | Defined | 2025-05-13 | |
| 2025-03-31 | $7,547,070 | 255,400 | Put | Defined | 2025-05-13 | |
| 2024-12-31 | $6,330,324 | 261,800 | Call | Defined | 2025-02-14 | |
| 2024-12-31 | $41,498,488 | 1,716,232 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $5,288,639 | 287,114 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $6,133,620 | 303,795 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,580,318 | 166,795 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,563,044 | 175,623 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $378,726 | 60,211 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $897,474 | 95,476 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $487,240 | 49,117 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $296,712 | 46,289 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $11,232 | 2,013 | Shares | Defined | 2022-11-10 | |
| 2021-12-31 | $35,408 | 5,406 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $67,143 | 8,905 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $24,839 | 2,281 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $61,519 | 4,650 | Shares | Defined | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||